Suchergebnisse - "Cheng, Shu"

PubPharm (32)

1

Salvage Surgery for Initially Unresectable HCC With PVTT Converted by Locoregional Treatment Plus Tyrosine Kinase Inhibitor and Anti-PD-1 Antibody

enthalten in: The oncologist | 2024

von Wang, L. | Feng, J. | Lu, C. | +11

2

Disulfidptosis-Associated lncRNAs are Potential Biomarkers for Predicting Immune Response and Prognosis Within Individuals Diagnosed with Hepatocellular Carcinoma

enthalten in: Hepatic medicine : evidence and research | 2023

von Wei, Q. | Hou, Y. | Mao, F. | +3

3

Surgical outcomes of hepatocellular carcinoma with extrahepatic bile duct tumor thrombus : a multicenter study

enthalten in: Frontiers in oncology | 2023

von Huang, L. | Zeng, Z. | Wu, J. | +10

4

Preoperative and Prognostic Prediction of Microvascular Invasion in Hepatocellular Carcinoma : A Review Based on Artificial Intelligence

enthalten in: Technology in cancer research & treatment | 2023

von Jiang, Y. | Wang, K. | Wang, Y. | +4

5

Cidan Capsule in Combination with Adjuvant Transarterial Chemoembolization Reduces Recurrence Rate after Curative Resection of Hepatocellular Carcinoma : A Multicenter, Randomized Controlled Trial

enthalten in: Chinese journal of integrative medicine | 2023

von Zheng, D. | Yang, J. | Wu, J. | +14

6

Hazard rate for postoperative recurrence in patients with hepatocellular carcinoma at Barcelona Clinic Liver Cancer stage 0 or A1 : A multicenter observational study

enthalten in: Hepatology research : the official journal of the Japan Society of Hepatology | 2022

von Xiang, Y. | Wang, K. | Yu, H. | +8

7

Transcatheter arterial chemoembolization plus atezolizumab and bevacizumab for unresectable hepatocellular carcinoma : a single-arm, phase II trial

enthalten in: Future oncology (London, England) | 2022

von Wang, K. | Yu, H. | Xiang, Y. | +7

8

Transarterial chemoembolization plus a PD-1 inhibitor with or without lenvatinib for intermediate-stage hepatocellular carcinoma

enthalten in: Hepatology research : the official journal of the Japan Society of Hepatology | 2022

von Xiang, Y. | Wang, K. | Yu, H. | +11

9

Cidan Capsule in Combination with Adjuvant Transarterial Chemoembolization Reduces Recurrence Rate after Curative Resection of Hepatocellular Carcinoma: A Multicenter, Randomized Controlled Trial

enthalten in: Chinese journal of integrative medicine | 2022

von Zheng, D. | Yang, J. | Wu, J. | +14

10

Cidan Capsule in Combination with Adjuvant Transarterial Chemoembolization Reduces Recurrence Rate after Curative Resection of Hepatocellular Carcinoma: A Multicenter, Randomized Controlled Trial

enthalten in: Chinese journal of integrative medicine | 2022

von Zheng, D. | Yang, J. | Wu, J. | +14